Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Origin Therapeutics Holdings, Inc. ( (TSE:SPLY) ) just unveiled an announcement.
Safe Supply Streaming Co Ltd. has completed the first sale under its exclusive Canadian distribution agreement with NIRLAB SA, supplying a NIRLIGHT spectroscopy drug analysis device to Far North Resources Inc. to support Indigenous-led community safety initiatives. The deployment of the NIRLAB system will give Indigenous communities rapid, non-contact drug analysis capabilities, enabling early risk detection, faster and more informed safety decisions, and improved situational awareness for frontline organizations, while also demonstrating the device’s six-second, lab-comparable accuracy that is increasingly relevant for broader public-safety and investigative applications.
More about Origin Therapeutics Holdings, Inc.
Safe Supply Streaming Co Ltd. is a health and safety technology company focused on rapid-response solutions for drug analysis and public safety. Through an exclusive Canadian distribution agreement with NIRLAB SA, it provides near-infrared spectroscopy devices designed for fast, non-destructive identification of substances, with a particular emphasis on supporting community-level health, safety, and evidence-based decision-making.
Average Trading Volume: 108,845
Technical Sentiment Signal: Sell
Current Market Cap: C$5.07M
See more data about SPLY stock on TipRanks’ Stock Analysis page.